Axonics (STU:0I3) Construction In Progress : €12.1 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Axonics Construction In Progress?

Axonics's quarterly construction in progress increased from Sep. 2023 (€1.6 Mil) to Dec. 2023 (€5.6 Mil) and increased from Dec. 2023 (€5.6 Mil) to Mar. 2024 (€12.1 Mil).

Axonics's annual construction in progress increased from Dec. 2021 (€0.1 Mil) to Dec. 2022 (€0.4 Mil) and increased from Dec. 2022 (€0.4 Mil) to Dec. 2023 (€5.6 Mil).

Axonics Construction In Progress Historical Data

The historical data trend for Axonics's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Axonics Construction In Progress Chart

Axonics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Construction In Progress

Get a 7-Day Free Trial

0.16

0.11

0.39

5.55

Axonics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Construction In Progress	Get a 7-Day Free Trial															0.79	0.73	1.63	5.55	12.08

Axonics Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Axonics (STU:0I3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Axonics Inc (STU:0I3) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

AXNX:USA 0I3:Germany

Address

26 Technology Drive, Irvine, CA, USA, 92618

Website

https://www.axonics.com

Axonics Inc is a United States-based medical technology company. It focuses on developing and commercializing novel products for adults with bladder and bowel dysfunction, that include implantable SNM systems to treat urinary urge incontinence and urinary urgency frequency (UUF); a urethral bulking agent (Bulkamid) to treat female stress urinary incontinence. SNM therapy is primarily used to treat patients with overactive bladder, fecal incontinence, and urinary retention.

Axonics (STU:0I3) Headlines

No Headlines